• Login
Saturday, March 21, 2026
Geneva Times
  • Home
  • Editorial
  • Switzerland
  • Europe
  • International
  • UN
  • Business
  • Sports
  • More
    • Article
    • Tamil
No Result
View All Result
  • Home
  • Editorial
  • Switzerland
  • Europe
  • International
  • UN
  • Business
  • Sports
  • More
    • Article
    • Tamil
No Result
View All Result
Geneva Times
No Result
View All Result
  • Home
  • Editorial
  • Switzerland
  • Europe
  • International
  • UN
  • Business
  • Sports
  • More
Home Switzerland

Trump’s promise to lower drug prices rattles Swiss pharma stocks

GenevaTimes by GenevaTimes
May 12, 2025
in Switzerland
Reading Time: 20 mins read
0
Trump’s promise to lower drug prices rattles Swiss pharma stocks
0
SHARES
0
VIEWS
Share on FacebookShare on Twitter


company sign

Roche and Novartis lost up to 3% in Zurich on Monday morning.


Keystone / Georgios Kefalas





Generated with artificial intelligence.

US President Trump wants to make medicines, some of which are exorbitantly expensive, cheaper in the US. This would mean huge losses for drugmakers, including those in Switzerland.


This content was published on


May 12, 2025 – 12:04

+Get the most important news from Switzerland in your inbox

Shares in the pharmaceutical sector have come under heavy pressure worldwide due to concerns about profitability in the US business. US President Donald Trump wants to lower prices for prescription drugs in the USA and is therefore targeting the entire industry.

One of the “most consequential decrees” in US history will be signed on Monday, the Republican announced on his online platform Truth Social. Trump had already held out the prospect of an “earth-shattering” announcement last week. US media had already speculated that it could be about drug prices.

The fact that Trump now wants to get serious has put pharmaceutical shares under heavy pressure internationally: the losses are likely to extend to the US stock markets via Japan and Europe. In European trading on Monday, Sanofi and Novo Nordisk were hit particularly hard with losses of almost 6%. Shares in AstraZeneca and GSK fell by up to 4% in London. Roche and Novartis lost up to 3% in Zurich. Pfizer was down 2.3% in pre-market trading in New York.

More

pills

More

US tariffs pressure Swiss pharma powerhouse




This content was published on


Apr 25, 2025



Looming US pharma tariffs could challenge the status quo in pharmaceutical hubs like Switzerland as investment shifts to the US.



Read more: US tariffs pressure Swiss pharma powerhouse


Trump wants to force pharmaceutical companies to accept internationally comparable prices. He sees his country at a disadvantage due to high prices. In the US, there is no central government price regulation that applies to all medicines. The pharmaceutical industry plays the most important role in the question of how much a drug costs – government influence is limited. This sometimes leads to enormously high prices – in an international comparison, many drugs in the US are significantly more expensive.

The world wonders why prescription drugs are so much more expensive in the US than in other countries around the world, even though they are produced in the same laboratory by the same company, Trump wrote. He promised that drug prices in the US would fall by 30-80% “almost immediately”.

Translated from German by DeepL/jdp

How we work

We select the most relevant news for an international audience and use automatic translation tools such as DeepL to translate them into English. A journalist then reviews the translation for clarity and accuracy before publication. Providing you with automatically translated news gives us the time to write more in-depth articles. The news stories we select have been written and carefully fact-checked by an external editorial team from news agencies such as Bloomberg or Keystone.

Did you find this explanation helpful? Please fill out the short survey below to help us understand your needs.


External Content

Don’t miss your chance to make a difference! Take our survey and share your thoughts.

Articles in this story

Swiss glaciers start the summer with little snow cover

More

Swiss glaciers start the summer with little snow cover




This content was published on


May 12, 2025



The Swiss glaciers are starting the summer season this year with a record-low snow pack in some places.



Read more: Swiss glaciers start the summer with little snow cover


Ethylene: Clariant sued by Dow Europe

More

Swiss chemical firm Clariant sued by Dow over price fixing




This content was published on


May 12, 2025



Clariant is facing a third complaint concerning breaches of competition law on the ethylene market.



Read more: Swiss chemical firm Clariant sued by Dow over price fixing


Charged with murder after shots fired on school playground in Maggia Valley

More

Trial opens in Switzerland for murder case of school caretaker




This content was published on


May 12, 2025



The trial of a man who allegedly killed a 41-year-old man with three shots in the Maggia Valley in May 2023 begins on Monday.



Read more: Trial opens in Switzerland for murder case of school caretaker


Big ESC parade reaches Kleinbasel

More

Eurovision opens with lively parade through Basel




This content was published on


May 12, 2025



In glorious May weather, Basel opened the Eurovision Song Contest (ESC) with a lively parade through the city.



Read more: Eurovision opens with lively parade through Basel


China and USA optimistic after customs talks in Geneva

More

China and US agree to lower tariffs after talks in Geneva




This content was published on


May 12, 2025



According to the Chinese delegation, China and the US reached a “series of important agreements” during their trade talks in Geneva.



Read more: China and US agree to lower tariffs after talks in Geneva


Majority of population in favour of social media ban for children

More

Vast majority of Swiss support social media ban for under-16s




This content was published on


May 11, 2025



Around 80% of people who took part in a recent survey in Switzerland said they were in favour of a social media ban for under-16s.



Read more: Vast majority of Swiss support social media ban for under-16s


Venice Biennale of Art: death of curator Koyo Kouoh

More

Koyo Kouoh, prominent art world figure, dies aged 58




This content was published on


May 11, 2025



Koyo Kouoh, curator of the 61st International Art Exhibition of La Biennale di Venezia, Biennale Arte 2026, has died, aged 58, it was announced on Saturday.



Read more: Koyo Kouoh, prominent art world figure, dies aged 58


One in 7 Swiss say they have lost money in a cyber scam

More

One in seven Swiss has lost money to cyber scam




This content was published on


May 11, 2025



One in seven adults in Switzerland has fallen victim to a cyber scam, according to a survey published by the SonntagsZeitung newspaper. One-third of victims have lost over CHF1,000 ($1,200).



Read more: One in seven Swiss has lost money to cyber scam


Bessent: towards Swiss investments of 150 to 200 billion euros

More

Treasury secretary says Swiss firms want to invest up to CHF200 billion in US




This content was published on


May 11, 2025



According to US Treasury Secretary Scott Bessent, Swiss companies have indicated their interest in investing CHF150-200 billion ($180-240 billion) in the United States.



Read more: Treasury secretary says Swiss firms want to invest up to CHF200 billion in US


China-US talks: Trump hails progress

More

Trump hails ‘great progress’ at US-China trade talks in Geneva




This content was published on


May 11, 2025



US President Donald Trump on Saturday welcomed the “great progress” made at talks between the US and China in Geneva on tariffs.



Read more: Trump hails ‘great progress’ at US-China trade talks in Geneva


Read More

Previous Post

Uzbekistan, EU discuss expansion of ties with focus on green energy

Next Post

NASCAR Cup Series: AdventHealth 400 Highlights | NASCAR on FOX

Next Post
NASCAR Cup Series: AdventHealth 400 Highlights | NASCAR on FOX

NASCAR Cup Series: AdventHealth 400 Highlights | NASCAR on FOX

ADVERTISEMENT
Facebook Twitter Instagram Youtube LinkedIn

Explore the Geneva Times

  • About us
  • Contact us

Contact us:

editor@thegenevatimes.ch

Visit us

© 2023 -2024 Geneva Times| Desgined & Developed by Immanuel Kolwin

Welcome Back!

Login to your account below

Forgotten Password?

Retrieve your password

Please enter your username or email address to reset your password.

Log In
No Result
View All Result
  • Home
  • Editorial
  • Switzerland
  • Europe
  • International
  • UN
  • Business
  • Sports
  • More
    • Article
    • Tamil

© 2023 -2024 Geneva Times| Desgined & Developed by Immanuel Kolwin